APUS 주가 차트
APUS 수입
Apimeds Pharmaceuticals US Inc
$1.88
0%
$0
종가: Apr 16, 16:00:00 GMT-4
$1.88
0%
$0
애프터마켓: Apr 16, 18:08:32 GMT-4
뒤로
Apimeds Pharmaceuticals US Inc (APUS) 수입
주요 통계
이전 종가
$1.88
시가
$1.69
일일 범위
$1.69 - $1.88
52주 범위
$1.6 - $40.31
거래량
31.5K
평균 거래량
17.9K
배당수익률
--
EPS(TTM)
--
시가총액
$23.6M
APUS란 무엇인가요?
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
